2m 2m 2m 2m 2m 2m 2m
STOKE THERAP (STOK)
NASDAQ
$29.36+$0.50 (+1.72%)
Price as of Aug 03, 2026 7:35 AM EDT- $1.8BMarket Cap
- 123.55%1-Year Change
- BiotechnologyIndustry
STOKE THERAP (STOK)
$29.36+$0.50 (+1.72%)
STOK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $28.86 | ||
Change | -$1.18 (-3.93%) | ||
Open | $29.75 | ||
High | $30.00 | ||
Low | $28.70 | ||
Previous Close | $30.04 | ||
Volume | 715,806 | ||
30-Day Average Volume | 670,506 | ||
1-Week Change | -1.50% | ||
1-Month Change | -11.80% | ||
1-Year Change | 123.55% | ||
3-Year Change | 334.64% | ||
5-Year Change | 0.80% | ||
Fundamentals | |||
Shares Outstanding | 62.3M | ||
Total Assets | $443.3M | ||
Market Cap | $1.8B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $6.2M | ||
Net Income | -$50.0M | ||
Free Cash Flow | -$60.9M | ||
EBIT | -$50.0M | ||
EBITDA | -$49.5M | ||
Net Working Capital | $325.9M | ||
EPS | -$0.79 | ||
Enterprise Value/EBITDA | -33 | ||
Enterprise Value/Revenue | 264 | ||
P/B | 5 | ||
P/E | -37 | ||
PEG | -2 | ||
Price/Free Cash Flow | -29 | ||
Price/Operating Cash Flow | -30 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue